Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)

MLA

Jochen Mueller-Cohrs, et al. “Pharmacological Characteristics of a Novel, Recombinant Fusion Protein Linking Coagulation Factor VIIa with Albumin (RVIIa-FP).” Journal of Thrombosis and Haemostasis, vol. 12, no. 2, Feb. 2014, pp. 220–28. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....053db74b93e3b7be50bc4621dc776437&authtype=sso&custid=ns315887.

APA

Jochen Mueller-Cohrs, Sabine Zollner, Stefan Schulte, Gerhard Dickneite, Ingo Pragst, Elmar Raquet, Daniel Schuermann, & Thomas Weimer. (2014). Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP). Journal of Thrombosis and Haemostasis, 12(2), 220–228.

Chicago

Jochen Mueller-Cohrs, Sabine Zollner, Stefan Schulte, Gerhard Dickneite, Ingo Pragst, Elmar Raquet, Daniel Schuermann, and Thomas Weimer. 2014. “Pharmacological Characteristics of a Novel, Recombinant Fusion Protein Linking Coagulation Factor VIIa with Albumin (RVIIa-FP).” Journal of Thrombosis and Haemostasis 12 (2): 220–28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....053db74b93e3b7be50bc4621dc776437&authtype=sso&custid=ns315887.